Metabolically healthy obesity: a friend or foe?

키워드

참고문헌 (73)

1. Kelly T, "Global burden of obesity in 2005 and projections to 2030", Int J Obes (Lond), 32, pp.1431~1437 (2008)
2. Mokdad AH, "Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001", JAMA, 289, pp.76~79 (2003)
3. Phillips CM., "Metabolically healthy obesity: definitions, determinants and clinical implications", Rev Endocr Metab Disord, 14, pp.219~227 (2013)
4. Stefan N, "Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications", Lancet Diabetes Endocrinol, 1, pp.152~162 (2013)
5. Samocha-Bonet D, "Metabolically healthy and unhealthy obese: the 2013 Stock Conference report", Obes Rev, 15, pp.697~708 (2014)
6. Bluher M., "Are metabolically healthy obese individuals really healthy?", Eur J Endocrinol, 171, pp.R209~R219 (2014)
7. Ruderman NB, "The “metabolically-obese,” normal-weight individual", Am J Clin Nutr, 34, pp.1617~1621 (1981)
8. Bluher M., "The distinction of metabolically ‘healthy’from ‘unhealthy’ obese individuals", Curr Opin Lipidol, 21, pp.38~43 (2010)
9. Kantartzis K, "Effects of a lifestyle intervention in metabolically benign and malign obesity", Diabetologia, 54, pp.864~868 (2011)
10. Karelis AD, "Metabolically healthy but obese women: effect of an energy-restricted diet", Diabetologia, 51, pp.1752~1754 (2008)
11. Perseghin G., "Is a nutritional therapeutic approach unsuitable for metabolically healthy but obese women?", Diabetologia, 51, pp.1567~1569 (2008)
12. Aguilar-Salinas CA, "High adiponectin concentrations are associated with the metabolically healthy obese phenotype", J Clin Endocrinol Metab, 93, pp.4075~4079 (2008)
13. Karelis AD, "Can we identify metabolically healthy but obese individuals (MHO)?", Diabetes Metab, 30, pp.569~572 (2004)
14. Wildman RP, "The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering:prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)", Arch Intern Med, 168, pp.1617~1624 (2008)
15. Meigs JB, "Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease", J Clin Endocrinol Metab, 91, pp.2906~2912 (2006)
16. Expert Panel on Detection, Evaluation, "Executive Summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
17. Stefan N, "Identification and characterization of metabolically benign obesity in humans", Arch Intern Med, 168, pp.1609~1616 (2008)
18. Hinnouho GM, "Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?", Diabetes Care, 36, pp.2294~2300 (2013)
19. Velho S, "Metabolically healthy obesity: different prevalences using different criteria", Eur J Clin Nutr, 64, pp.1043~1051 (2010)
20. Stefan N, "Mechanisms explaining the relationship between metabolically healthy obesity and cardiovascular risk", J Am Coll Cardiol, 63, pp.2748~2749 (2014)
21. Jung CH, "The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation", J Clin Endocrinol Metab, 100, pp.934~941 (2015)
22. 유호권, "Comparison of Metabolic Characteristics of Metabolically Healthy but Obese (MHO) Middle-Aged Men According to Different Criteria", Korean Journal of Family Medicine, 34(1), pp.19~26 (2013), 대한가정의학회
23. Rey-Lopez JP, "The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used", Obes Rev, 15, pp.781~790 (2014)
24. Shea JL, "The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry", Obesity (Silver Spring), 19, pp.624~630 (2011)
25. Soriguer F, "Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study", J Clin Endocrinol Metab, 98, pp.2318~2325 (2013)
26. Lee SK, "Obesity phenotype and incident hypertension: a prospective community-based cohort study", J Hypertens, 31, pp.145~151 (2013)
27. Appleton SL, "Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study", Diabetes Care, 36, pp.2388~2394 (2013)
28. Schroder H, "Determinants of the transition from a cardiometabolic normal to abnormal overweight", obese phenotype in a Spanish population, 2014, pp.53, 1345~1353
29. Hwang YC, "Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype", Int J Obes (Lond), 39, pp.1365~1370 (2015)
30. Spalding KL, "Dynamics of fat cell turnover in humans", Nature, 453, pp.783~787 (2008)
31. Torres-Perez E, "The FAT expandability (FATe) project: biomarkers to determine the limit of expansion and the complications of obesity", Cardiovasc Diabetol, 14, pp.40~ (2015)
32. Doumatey AP, "Proinflammatory and lipid biomarkers mediate metabolically healthy obesity: a proteomics study", Obesity (Silver Spring), 24, pp.1257~1265 (2016)
33. Esser N, "Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue", Diabetologia, 56, pp.2487~2497 (2013)
34. Phillips CM, "Does inflammation determine metabolic health status in obese and nonobese adults?", J Clin Endocrinol Metab, 98, pp.E1610~E1619 (2013)
35. Karelis AD, "The metabolically healthy but obese individual presents a favorable inflammation profile", J Clin Endocrinol Metab, 90, pp.4145~4150 (2005)
36. Gomez-Ambrosi J, "Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy", Diabetes Care, 37, pp.2014~2037 (2014)
37. Wildman RP, "Body size phenotypes and inflammation in the Women’s Health Initiative Observational Study", Obesity (Silver Spring), 19, pp.1482~1491 (2011)
38. Jung CH, "The risk of chronic kidney disease in a metabolically healthy obese population", Kidney Int, 88, pp.843~850 (2015)
39. Jung CH, "Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity", Obesity (Silver Spring), 24, pp.1373~1379 (2016)
40. Hinnouho GM, "Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study", Eur Heart J, 36, pp.551~559 (2015)
41. Twig G, "Diabetes risk among overweight and obese metabolically healthy young adults", Diabetes Care, 37, pp.2989~2995 (2014)
42. Aung K, "Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals", J Clin Endocrinol Metab, 99, pp.462~468 (2014)
43. Rhee EJ, "Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study", PLoS One, 9, pp.e98369~ (2014)
44. Bell JA, "Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies", Obes Rev, 15, pp.504~515 (2014)
45. Yoon KH, "Epidemic obesity and type 2 diabetes in Asia", Lancet, 368, pp.1681~1688 (2006)
46. Razak F, "Defining obesity cut points in a multiethnic population", Circulation, 115, pp.2111~2118 (2007)
47. Bedogni G, "The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population", BMC Gastroenterol, 6, pp.33~ (2006)
48. Sowers JR, "Diabetes, hypertension, and cardiovascular disease: an update", Hypertension, 37, pp.1053~1059 (2001)
49. Ding WQ, "Hypertension outcomes in metabolically unhealthy normal-weight and metabolically healthy obese children and adolescents", J Hum Hypertens, 29, pp.548~554 (2015)
50. Kang YM, "The association of incident hypertension with metabolic health and obesity status:definition of metabolic health does not matter", Clin Endocrinol (Oxf ), 85, pp.207~215 (2016)
51. Ruster C, "Adipokines promote chronic kidney disease", Nephrol Dial Transplant, 28(Suppl 4), pp.iv8~iv14 (2013)
52. Henry RM, "Mild renal insufficiency is associated with increased cardiovascular mortality:the Hoorn Study", Kidney Int, 62, pp.1402~1407 (2002)
53. Chang Y, "Metabolically healthy obesity and development of chronic kidney disease: a cohort study", Ann Intern Med, 164, pp.305~312 (2016)
54. Hashimoto Y, "Metabolically healthy obesity and risk of incident CKD", Clin J Am Soc Nephrol, 10, pp.578~583 (2015)
55. Wahba IM, "Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease", Clin J Am Soc Nephrol, 2, pp.550~562 (2007)
56. Ejerblad E, "Obesity and risk for chronic renal failure", J Am Soc Nephrol, 17, pp.1695~1702 (2006)
57. Khan UI, "Burden of subclinical cardiovascular disease in “metabolically benign”and “at-risk” overweight and obese women: the Study of Women’s Health Across the Nation (SWAN)", Atherosclerosis, 217, pp.179~186 (2011)
58. Marini MA, "Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women", Diabetes Care, 30, pp.2145~2147 (2007)
59. Jung CH, "Association of metabolically healthy obesity with subclinical coronary atherosclerosis in a Korean population", Obesity (Silver Spring), 22, pp.2613~2620 (2014)
60. Chang Y, "Metabolically-healthy obesity and coronary artery calcification", J Am Coll Cardi ol, 63, pp.2679~2686 (2014)
61. Yoo HJ, "Vascular inflammation in metabolically abnormal but normal-weight and metabolically healthy obese individuals analyzed with 18F-fluorodeoxyglucose positron emission tomography", Am J Cardiol, 115, pp.523~528 (2015)
62. Sung KC, "Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis", Nutr Metab Cardiovasc Dis, 24, pp.256~262 (2014)
63. Rhee EJ, "Metabolic health is more closely associated with coronary artery calcification than obesity", PLoS One, 8, pp.e74564~ (2013)
64. Kramer CK, "Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis", Ann Intern Med, 159, pp.758~769 (2013)
65. Alpert JS., "“So, doctor, what’s so bad about being fat?”Combating the obesity epidemic in the United States", Am J Med, 123, pp.1~2 (2010)
66. Jae SY, "Metabolically healthy obesity and carotid intima-media thickness:effects of cardiorespiratory fitness", Mayo Clin Proc, 90, pp.1217~1224 (2015)
67. Kang YM, "Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population", PLoS One, 12, pp.e0175762~ (2017)
68. Zheng R, "The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis", J Epidemiol Community Health, 70, pp.1024~1031 (2016)
69. Eckel N, "Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis", Eur J Prev Cardiol, 23, pp.956~966 (2016)
70. Choi KM, "Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans", Clin Endocrinol (Oxf ), 79, pp.364~370 (2013)
71. "Health topics: obesity" (2017)[URL]
72. "WHO definition of health" (2017)[URL]
73. Sharma AM, "A proposed clinical staging system for obesity", Int J Obes (Lond), 33, pp.289~295 (2009)

관련 논문AI추천